Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Glioma × Hydroxyurea × Clear all

Phase

Status

Completed 2 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Chronic-Phase 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Leukemia 3 Squamous Cell Carcinoma of Head and Neck 1 Meningioma 1 Lung Neoplasms 1 Leukemia, Promyelocytic, Acute 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Head and Neck Neoplasms 1 Glioma 1 Glioblastoma 1 Esophageal Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1

Interventions

Temozolomide 14 Radiotherapy 7 apatinib 4 anlotinib 3 Surgical Procedures, Operative 3 Chlorotoxin 3 Positron Emission Tomography Computed Tomography 2 Pemetrexed 2 Magnetic Resonance Spectroscopy 2 Lomustine 2 Immunotherapy, Adoptive 2 Blood Specimen Collection 2 Bevacizumab 2 Aminolevulinic Acid 2 sodium thiosulfate 1 ribociclib 1 poly ICLC 1 etoposide phosphate 1 Vinblastine 1 Valproic Acid 1 Tranexamic Acid 1 Surveys and Questionnaires 1 Rivaroxaban 1 Radiosurgery 1 Radiation 1 Propofol 1 Polymerase Chain Reaction 1 Poly I-C 1 Metformin 1 Metabolism 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03463733 2020-10-08

HUTMZ

Amsterdam UMC, location VUmc

Phase 1 Unknown

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡